Sickle cell patients continue experimental drug to monitor Long-Term safety

NCT ID NCT05348915

Terminated Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

Summary

This study aimed to check the long-term safety of inclacumab, an experimental drug for sickle cell disease. It was for people who had already received the drug in a previous Pfizer trial. Participants received the drug every 12 weeks, and researchers tracked any side effects and hospital visits related to their condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Acibadem Adana Hastanesi Cocuk Hematoloji Onkoloji

Adana, 01130, Turkey (Türkiye)
Ahmadu Bello University Teaching Hospital

Zaria, Kaduna State, 810105, Nigeria
American University of Beirut Medical Center

Hamra, Beyrouth, Lebanon
Aminu Kano Teaching Hospital

Kano, 700223, Nigeria
Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States
Barau Dikko Teaching Hospital/Kaduna State University

Kaduna, 800212, Nigeria
Baskent University Adana Appl. and Research Central, Yuregir Baskent Hospital Hematology

Adana, 01250, Turkey (Türkiye)
Brigham And Woman's Hospital

Boston, Massachusetts, 02115, United States
CEPEC-Centro de Pesquisa Clinica

São Paulo, 08270-120, Brazil
Casa de Saude Santa Marcelina

São Paulo, 08270-070, Brazil
Clinica de la Costa Ltda.

Barranquilla, Atlántico, 080020, Colombia
DUMC Investigational Drug Services Pharmacy

Durham, North Carolina, 27710, United States
Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Dana-Farber Cancer Institute IDS Pharmacy

Boston, Massachusetts, 02215, United States
Department of Pediatrics, College of Medicine, Lagos University Teaching Hospital

Lagos, 100254, Nigeria
Duke University Medical Center

Durham, North Carolina, 27705, United States
Fundação Faculdade Regional de Medicina de São José do Rio Preto

São José do Rio Preto, São Paulo, 15090-000, Brazil
Gertrude's Children's Hospital

Nairobi, 00100, Kenya
Hacettepe University Ihsan Dogramaci Children Hospital

Ankara, 06430, Turkey (Türkiye)
Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP

Ribeirão Preto, São Paulo, 14051-140, Brazil
Hospital Samaritano Higienópolis/Esho Empresa De Servicos Hospitalares S.A

São Paulo, 01232-010, Brazil
Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Instituto D'Or de Pesquisa e Ensino - Hospital São Rafael

Salvador, Estado de Bahia, 41253-190, Brazil
Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti - HEMORIO

Rio de Janeiro, 20211-030, Brazil
International Cancer Institute

Eldoret, 30100, Kenya
Jacobi Medical Center

The Bronx, New York, 10461, United States
KEMRI/CRDR Siaya Clinical Research Annex

Kisumu, Siaya County, 40600, Kenya
Kenya Medical Research Institute - Centre for Respiratory Disease Research

Nairobi, 00100, Kenya
McGovern Medical School at UTHealth

Houston, Texas, 77030, United States
Multihemo Servicos Medicos S/A

Recife, Pernambuco, 50070-460, Brazil
National Hospital Abuja

Abuja, Federal Capital Territory, 900211, Nigeria
National Institute for Medical Research (NIMR)

Dar es Salaam, 11101, Tanzania
Nini Hospital

Tripoli, North Lebanon, Lebanon
Prince Mohammed bin Nasser Hospital

Jizan, Southern, 82943, Saudi Arabia
Sociedad de Oncología y hematología del Cesar

Valledupar, Cesar Department, 200001, Colombia
South Alabama Medical Science Foundation

Mobile, Alabama, 36606, United States
Strada Patient Care Center, Pediatric Hematology

Mobile, Alabama, 36604, United States
Strathmore University CREATES

Nairobi, 00200, Kenya
Sultan Qaboos University Hospital

Muscat, 123, Oman
UC Irvine Medical Center

Orange, California, 92868, United States
UConn-Neag Comprehensive Cancer Center

Farmington, Connecticut, 06030, United States
UT Health Science Center at Houston - Clinical Research Unit at Memorial Hermann Hospital

Houston, Texas, 77030, United States
UT Physicians Comprehensive Sickle Cell Center Houston

Houston, Texas, 77030, United States
University of Abuja Teaching Hospital

Gwagwalada, Federal Capital Territory, 902101, Nigeria
University of Calabar Teaching Hospital

Calabar, Cross River State, 540242, Nigeria
University of Illinois Hospital and Health Sciences System (UI Health)

Chicago, Illinois, 60612, United States
University of Illinois at Chicago (UIC) Clinical Research Center

Chicago, Illinois, 60612, United States
University of Michigan Hospitals - Michigan Medicine

Ann Arbor, Michigan, 48109, United States
University of Nigeria Teaching Hospital

Enugu, 460000, Nigeria
University of South Alabama Children's and Women's Hospital

Mobile, Alabama, 36604, United States

Conditions

Explore the condition pages connected to this study.

SICKLE CELL DISEASE VASO-OCCLUSIVE CRISIS VASO-OCCLUSIVE PAIN EPISODE IN SICKLE CELL DISEASE